BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 30132244)

  • 1. Omission of Antiplatelet Therapy in Patients With HeartMate 3 Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis.
    Tscharre M; Mutschlechner D; Schlöglhofer T; Wiedemann D; Zimpfer D; Gremmel T
    ASAIO J; 2024 May; ():. PubMed ID: 38728742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
    Turpie AG; Gent M; Laupacis A; Latour Y; Gunstensen J; Basile F; Klimek M; Hirsh J
    N Engl J Med; 1993 Aug; 329(8):524-9. PubMed ID: 8336751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy after heart valve surgery: contemporary practice in the UK.
    Laskar N; Bayliss CD; Kirmani BH; Chambers JB; Maier R; Briffa NP; Cartwright N; Kendall S; Shah BN; Akowuah E
    Interdiscip Cardiovasc Thorac Surg; 2024 May; 38(5):. PubMed ID: 38704867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern Treatment of Valvulopathies in Patients with Congenital Hemophilia.
    Badescu MC; Badulescu OV; Gheorghe L; Butnariu LI; Ouatu A; Popescu D; Buliga-Finiș ON; Gorduza EV; Ciocoiu M; Rezus C
    Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. At the Crossroads of Minimally Invasive Mitral Valve Surgery-Benching Single Hospital Experience to a National Registry: A Plea for Risk Management Technology.
    Cocchieri R; van de Wetering B; van Tuijl S; Mousavi I; Riezebos R; de Mol B
    J Cardiovasc Dev Dis; 2022 Aug; 9(8):. PubMed ID: 36005425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valve Replacement or Repair.
    Mentias A; Saad M; Michael M; Nakhla S; Menon V; Harb S; Chaudhury P; Johnston D; Saliba W; Wazni O; Svensson L; Desai MY; Kapadia S
    J Am Heart Assoc; 2022 Sep; 11(17):e026666. PubMed ID: 36000413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which antithrombotic strategy provides the best outcomes after mitral valve repair in patients who remain in sinus rhythm?
    Trevis J; Akowuah E
    Interact Cardiovasc Thorac Surg; 2022 Aug; 35(3):. PubMed ID: 35439299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2021 ESC/EACTS Guidelines for the management of valvular heart disease.
    Vahanian A; Beyersdorf F; Praz F; Milojevic M; Baldus S; Bauersachs J; Capodanno D; Conradi L; De Bonis M; De Paulis R; Delgado V; Freemantle N; Haugaa KH; Jeppsson A; Jüni P; Pierard L; Prendergast BD; Sádaba JR; Tribouilloy C; Wojakowski W
    EuroIntervention; 2022 Feb; 17(14):e1126-e1196. PubMed ID: 34931612
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic Treatment After Surgical and Transcatheter Heart Valve Repair and Replacement.
    Verstraete A; Herregods MC; Verbrugghe P; Lamberigts M; Vanassche T; Meyns B; Oosterlinck W; Rega F; Adriaenssens T; Van Hoof L; Keuleers S; Vandenbriele C; Sinnaeve P; Janssens S; Dubois C; Meuris B; Verhamme P
    Front Cardiovasc Med; 2021; 8():702780. PubMed ID: 34422930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
    van der Wall SJ; Umans VA; Schotten J; Keijzers M; Wolterbeek R; Jansen EK; Huisman MV; Vonk AB
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1157-63. PubMed ID: 26233944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of major bleeding events on aspirin versus vitamin K antagonists in randomized trials.
    Ambrosi P; Daumas A; Villani P; Giorgi R
    Int J Cardiol; 2017 Mar; 230():572-576. PubMed ID: 28063671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Salem DN; Stein PD; Al-Ahmad A; Bussey HI; Horstkotte D; Miller N; Pauker SG
    Chest; 2004 Sep; 126(3 Suppl):457S-482S. PubMed ID: 15383481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy after mitral valve repair: VKA or aspirin?
    van der Wall SJ; Olsthoorn JR; Heuts S; Klautz RJM; Tomsic A; Jansen EK; Vonk ABA; Sardari Nia P; Klok FA; Huisman MV
    J Thromb Thrombolysis; 2018 Nov; 46(4):473-481. PubMed ID: 30132244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Whitlock RP; Sun JC; Fremes SE; Rubens FD; Teoh KH
    Chest; 2012 Feb; 141(2 Suppl):e576S-e600S. PubMed ID: 22315272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair.
    Paparella D; Di Mauro M; Bitton Worms K; Bolotin G; Russo C; Trunfio S; Scrofani R; Antona C; Actis Dato G; Casabona R; Colli A; Gerosa G; Renzulli A; Serraino F; Scrascia G; Zaccaria S; De Bonis M; Taramasso M; Delgado L; Tritto F; Marmo J; Parolari A; Myaseodova V; Villa E; Troise G; Nicolini F; Gherli T; Whitlock R; Conte M; Barili F; Gelsomino S; Lorusso R; Sciatti E; Marinelli D; Di Giammarco G; Calafiore AM; Sheikh A; Alfonso JJ; Glauber M; Miceli A;
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1302-8.e1. PubMed ID: 26832208
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.